Concepedia

Author

Clarence Hale

Amgen (United States)ORCID

Also Known As

C. Hale, C. W. HALE, C. W. Hale, Calib Hale, Cecilia Hale, Clarence Hale, Hale, C., Hale, Clarence, M. Buford

74

Publications

4.3K

Citations

33

H-Index

110

Concepts

All Affiliations

Amgen (United States)Medical Research CouncilLister Institute of Preventive MedicineUniversity of OxfordSwedish Orphan Biovitrum (Sweden)
CH

About

Clarence Hale is an author at Amgen (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

33

2.4K

2

Natural Sciences

12

13

632

3

Health Sciences

11

11

1.1K

4

Education

1

1

13

5

Engineering

1

1

22

Clarence Hale

×

45

Publications

3.9K

Citations

30

H-Index

YearCitations

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

Jing Xu, David J. Lloyd, Clarence Hale,

Diabetes

2008

1.1K

Histochemical Demonstration of Acid Polysaccharides in Animal Tissues

Clarence Hale

Nature

1946

380

Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys

Yumei Xiong, Kenneth W. Walker, Xiaoshan Min,

Science Translational Medicine

2017

226

Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models

Elizabeth A. Killion, Jinghong Wang, Junming Yie,

Science Translational Medicine

2018

217

Lack of Overt FGF21 Resistance in Two Mouse Models of Obesity and Insulin Resistance

Clarence Hale, Michelle Chen, Shanaka Stanislaus,

Endocrinology

2011

179

FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice

Murielle M. Véniant, Clarence Hale, Joan Helmering,

PLoS ONE

2012

142

Chemico-anatomic studies in the geographic pathology of arteriosclerosis: A comparison of fatty acids of adipose tissue and of plasma lipids in nondiabetics and diabetics from Guatemala and the United States

R.F. Scott, Clarence Hale, Thomas Hale,

Experimental and Molecular Pathology

1962

108

Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors

David J. Lloyd, David J. St. Jean, Robert J. Kurzeja,

Nature

2013

96

Structure−Activity Relationships of a Series of Pyrrolo[3,2-<i>d</i>]pyrimidine Derivatives and Related Compounds as Neuropeptide Y5 Receptor Antagonists

Mark H. Norman, Ning Chen, Zhidong Chen,

Journal of Medicinal Chemistry

2000

84

Discovery of a Potent, Orally Active 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor for Clinical Study: Identification of (<i>S</i>)-2-((1<i>S</i>,2<i>S</i>,4<i>R</i>)-Bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5<i>H</i>)-one (AMG 221)

Murielle M. Véniant, Clarence Hale, Randall W. Hungate,

Journal of Medicinal Chemistry

2010

80

Page 1